Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Massive cancer biobank aims to fuel precision medicine breakthroughs

NCT ID NCT01499394

Knowledge-focused Sponsor: Caris Science, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is creating a large collection of blood and tissue samples from 100,000 adults with cancer. The samples and medical information will be stored and shared with researchers to develop better tests and treatments. The goal is to advance precision medicine and improve early detection of cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 100,000 people

The number the study aims to enrol. It can still change while the study runs.

Start date

Nov 2010

Expected to finish

Nov 2035

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Healthy volunteers as well as those with a known disease state or condition

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years of age or older * Capacity to provide informed consent Exclusion Criteria: * Due to the complexity of state and federal requirements governing the participation of prisoners in research, prisoners-patients will not be approached for participation in the Caris Biorepository. * Minor subjects will not be included in the Caris Biorepository, as it is possible biospecimens and data may be stored beyond the time limitations of assent and it may be impracticable to re-consent these subjects once they become adults. * Individuals who lack the capacity to give informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer neoplasm Neoplasm, Residual

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer Early detection of cancer Minimal residual disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    38 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Advent Health

    RECRUITING

    Orlando, Florida, United States

  • Altru Health System

    RECRUITING

    Grand Forks, North Dakota, United States

  • Augusta University Research Institute

    RECRUITING

    Augusta, Georgia, United States

  • Bend Memorial Clinic

    RECRUITING

    Bend, Oregon, United States

  • CAMC Clinical Trials

    RECRUITING

    Charleston, West Virginia, 25304, United States

  • CARTI Cancer Center

    RECRUITING

    Little Rock, Arkansas, United States

  • CHRISTUS - Highland Medical Center

    RECRUITING

    Shreveport, Louisiana, United States

  • CHRISTUS - St. Frances Cabrini Hospital

    RECRUITING

    Alexandria, Louisiana, United States

  • CHRISTUS - St. Michael's Health

    RECRUITING

    Texarkana, Texas, United States

  • CHRISTUS - St. Vincent Regional Cancer Center

    RECRUITING

    Santa Fe, New Mexico, United States

  • Cancer Care of North Florida

    RECRUITING

    Lake City, Florida, United States

  • Cancer Center of Middle Georgia

    RECRUITING

    Dublin, Georgia, United States

    Contact Email: •••••@•••••

  • Cleveland Clinic Florida

    RECRUITING

    Weston, Florida, United States

  • Clinical Biotechnology Research Institute at RSFH

    RECRUITING

    Charleston, South Carolina, United States

  • Emory University

    RECRUITING

    Atlanta, Georgia, United States

  • Great Lakes Medical Research

    RECRUITING

    Cleveland, Ohio, United States

  • Hattiesburg Clinic

    RECRUITING

    Hattiesburg, Mississippi, United States

  • Hope and Healing Cancer Services

    RECRUITING

    Hinsdale, Illinois, United States

  • Jackson Oncology Associates

    RECRUITING

    Jackson, Mississippi, United States

  • Lee Memorial Health System

    RECRUITING

    Fort Myers, Florida, United States

  • Mercy Health

    RECRUITING

    Janesville, Wisconsin, United States

  • Mercy Medical Center

    RECRUITING

    Baltimore, Maryland, United States

  • NEO Urology Associates

    RECRUITING

    Boardman, Ohio, United States

  • National Translational Research Group

    RECRUITING

    Ridge, New York, United States

  • ObjectiveHealth - ARcare Center for Clinical Research

    RECRUITING

    Little Rock, Arkansas, United States

  • ObjectiveHealth - Amarillo Premier Research

    RECRUITING

    Amarillo, Texas, United States

  • ObjectiveHealth - Premier Health Research

    RECRUITING

    Sparta, New Jersey, United States

  • Phoebe Putney Memorial Hospital

    RECRUITING

    Albany, Georgia, 31701, United States

  • Sinai Hospital of Baltimore

    RECRUITING

    Baltimore, Maryland, United States

  • Southwest Medical Imaging

    RECRUITING

    Scottsdale, Arizona, United States

  • Spartanburg Regional Health Services

    RECRUITING

    Spartanburg, South Carolina, United States

  • St. Bernards Medical Center

    RECRUITING

    Jonesboro, Arkansas, United States

  • St. Lawrence Health System

    RECRUITING

    Potsdam, New York, United States

  • The University of South Florida

    RECRUITING

    Tampa, Florida, United States

  • Tulane University

    RECRUITING

    New Orleans, Louisiana, United States

  • University of Mississippi Medical Center

    RECRUITING

    Jackson, Mississippi, United States

  • University of South Alabama

    RECRUITING

    Mobile, Alabama, United States

  • West Cancer Center

    RECRUITING

    Germantown, Tennessee, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.